Thrombosis Flashcards

1
Q

Diagram the in vitro coagulation pathways (intrinsic and extrinsic).

A

Intrinsic:
12 —> 11 —> 9 —(with 8 + Ca)—> [10 —(with 5 and Ca)—> 2 —(with Ca)—> fibrinogen to fibrin —(with 13)—> cross-linked fibrin]
(12, 11, 9 with 8 to [10, with 5 to 2, fibrinogen to fibrin, with 13 forms cross-links])

Extrinsic:
TF + 7 —> [10 —(with 5 and Ca)—> 2 —(with Ca)—> fibrinogen to fibrin —(with 13)—> cross-linked fibrin]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagram the in vivo (“new”) coagulation pathway.

A

TF + 7 —> 9 —(with 8)—> 10 —(with 5)—> 2(prothrombin to thrombin) —> fibrinogen —> fibrin monomers —> fibrin polymers —(with 13)—> fibrin clot

(TF and 7 to 9, with 8 to 10, with 5 to 2, fibrinogen to fibrin monomers then polymers, with 13 to fibrin clot)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain how PT tests are performed.

A

Measures EXTRINSIC pathway

Plasma + TF + Ca + phospholipids -> measure time to clot

Normal = 12-14 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain how PTT tests are performed.

A

Measures INTRINSIC pathway

Plasma + contact activator + phospholipid -> wait 5 min -> add CaCl2 -> measure time to clot

Normal = 23-33 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name the four stages of hemostasis and explain what is occurring in each.

A
  1. Reflex vasoconstriction at site of injury
    - Neurogenic mechanism via local release of chemical mediators
  2. Platelets come to site of action
    - VWF (von Willebrand factor): platelets adhere to sub-endothelial matrix via VWF
    - Platelets become activated: increase surface area, aggregate
  3. Coagulation cascade forms a clot
    - Tissue factor starts the coagulation cascade
    - See thrombin activation and fibrin polymerization
  4. Thrombus and antithrombotic events
    - Endothelium releases t-PA, thrombomodulin, trapped neutrophils and RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the 3 A’s associated with the role of platelets in hemostasis.

A

Their role in primary hemostasis–
Adhesion - VWF mediates adhesion to subendothelium at site of injury

Activation - metabolic activity increases secretion, increases surface area, and results in surface protein GPIIb/IIIa alteration

Aggregation - fibrinogen cross-links the GPIIb/IIIa, mechanical contraction occurs via actomyosin, surface phospholipid exposed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name three functions of von Willebrands factor.

A
  1. Adhesion - undergoes conformational change on binding to sub-endothelial collages -> binding to platelet GP1b
  2. Aggregation - binds platelet GPIIb/IIIa
  3. Factor 8 binding - binds factor 8 to site of hemorrhage, protects from cleavage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the role of factor 13 in coagulation.

A

Stabliizes the fibrin clot by cross-linking the lysine and glutamine side chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name the three inherent anticoagulant systems/mechanisms in the blood.

A
  1. Antithrombin: binds heparin-like molecules, makes conformational change so they can bind thrombin (IIa)
    - Effect: neutralize master regulator -> neutralize everything
  2. Thrombomodulin: binds thrombin and protein c -> APC, which is antithrombotic
    - APC binds protein S -> inactivates factors 5 and 8
  3. Fibrinolytic system: functions in clot lysis
    - Plasminogen (from liver) activated by…
    - —Tissue plasminogen activator (from endothelial cells) at clot site, bound to fibrin
    - —Urokinase-PA
    - —Streptokinase
    - …to plasmin, a serine protease
    - —Cleaves fibrin –> D-D dimer, other fragments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Identify four types of hemophilia and the factors that are deficient in each.

A

von Willebrand’s disease: VWF
Hemophilia A: Factor 8
Hemophilia B: Factor 9
Hemophilia C: Factor 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name the three components of “Virchow’s triad” active in thrombosis.

A
  1. Endothelial injury
  2. Alterations in blood flow
  3. Hypercoagulability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain the abnormality present in factor V Leiden hypercoagulability.

A

AA change in Activated Protein C (APC) cleavage site on Factor 5a molecule -> APC cannot inactivate it

Factor 5 persists longer -> increased thrombin generation -> hypercoagulable state

Worsened with OCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss the etiological, clinical, and laboratory findings associated with DIC.

A

DIC: disseminated intravascular coagulation; a pathologic, consumptive coagulopathy

Widespread, inappropriate coagulation in microvessels -> thrombosis -> consumption of procoagulants -> hemorrhage

Laboratory:

  • -Thrombocytopenia
  • -Prolonged screening coagulation tests
  • -Elevated fibrin degradation products (D-dimer)
  • -Fragmented red blood cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Calculate an INR from a patient’s PT value and the normalized PT value.

A

INR: international normalized ratio
—Target = 2-3

INR = (patient PT/mean normal PT for lab) ^ ISI

ISI = international sensitivity index
Higher ISI = less sensitive reagent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the mechanism behind three forms of antiplatelet (may not need to know).

A

Aspirin: irreversibly inhibits COX-1 in platelets (would otherwise make thromboxane A2)
NSAIDs reversibly inhibit COX-1
Clopidogrel/Plavix block ADP receptor
Abciximag blocks GPIIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hemostasis

A

Maintenance of blood in a fluid, thrombus-free state under normal conditions
Induce a rapid and localized hemostatic plug at a site of vessel injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Thrombosis

A

Inappropriate clot formation, a pathologic process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Procoagulants

A

Clot promoting components of blood and blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Anticoagulants

A

Clot inhibiting or clot dissolving components of blood or blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Primary hemostatic plug

A

Initial phase of cessation of bleeding
Brought about at the site of vessel injury by adhesion and aggregation of platelets to vessel wall and to other platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Secondary hemostatic plug

A

The stabilization of the primary hemostatic plug by the generation of fibrin from plasma proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Coagulation cascade

A

A series of sequential, enzymatic conversions turning proenzymes into activated enzymes culminating in the formation of fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Fibrinolysis

A

The controlled breakdown and remodeling of fibrin at the site of thrombus formation to reestablish blood flow in an affected blood vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Thrombophilia

A

Hereditary and acquired defects, primarily in anticoagulant components of the blood, which result in increased risk for thrombosis

25
Q

Describe the general process of hemostasis, from injury to healing and repair.

A
  1. Injury to vessel
  2. Platelet activation - plug
  3. Coagulation cascade - fibrin clot
    - Control of clot extension by antithrombotic mechanisms (clot must stay at site of injury)
    - Fibrinolysis and clot removal (when clot has done its work)
  4. Healing and repair
26
Q

Tissue factor

A

Anything the blood recognizes as non self

27
Q

Explain the roles of endothelial cells in thrombosis. (4)

A
  1. Maintain blood fluidity
    - Secrete endothelin -> vasoconstriction
    - Prevent platelet aggregation/promote vasodilation by secreting prostacyclin and NO
  2. Anticoagulant
    - Prevent interactions with adhesive proteins (collagen, VWF, TF)
    - Secrete membrane-associated heparin-like molecules heparin sulfate and thrombomodulin
  3. Modulate fibrinolysis
    - Make tissue plasminogen activator (tPA) and plasminogen activator inhibitors (PAI)
  4. Prothrombotic properties
    - Make/store/release VWF
    - Store/release Factor 8 in Weibel-Palade bodies
    - Make tissue factor - triggers initiation of coagulation
28
Q

Name the two unusual organelles found in platelets and what each contains.

A

Dense body: ATP, ADP, serotonin, calcium

Alpha granule: VWF, factor 5, platelet factor 4, fibrinogen

29
Q

Name the two sites of synthesis of VWF.

A

Weibel-palade body (endothelial cells, constituitive or stimulated secretion)

Platelet alpha-granule (platelet, stimulated secretion)

30
Q

What is the quaternary complex?

A

Collection of everything (enzyme [coag factor], cofactor, phospholipid, Ca2+) onto the phospholipid surface of the platelets

Makes it more efficient

31
Q

What is factor 1?

A

Fibrinogen

32
Q

What is factor 2?

A

Prothrombin

33
Q

What is factor 3?

A

Tissue factor/thromboplastin

34
Q

What is factor 4?

A

Calcium

35
Q

What is factor 8?

A

Antihemophilic A factor

36
Q

What is factor 9?

A

Antihemophilic B/Christmas factor

37
Q

What is factor 12?

A

Hageman factor

38
Q

Which four factors are vitamin K dependent?

A

2, 7, 9, 10

39
Q

What is the master conductor of coagulation?

A

Thrombin (IIa): activates 9, 8, and 5; also 13, fibrinolysis and platelets

40
Q

What systems are in place as a check on the fibrinolytic system?

A

Plasminogen activator inhibitor-1: inactivates excess t-PA that escapes into plasma
Alpha-2 antiplasmin: inactivates plasmin that escapes into plasma

41
Q

Name the three general causes of hemorrhage and examples of the two that we studied.

A
  1. Vessel wall abnormalities
  2. Primary hemostasis related abnormalities: -> mucosal bleeding
    - vWD, Bernard-Soulier, Glanzman Thrombasthenia
  3. Secondary hemostasis related abnormalities: -> bleeding into joints
    - Deficiency in factors (hemophilia, Christmas disease)
42
Q

What is the most common inherited hemorrhage disorder?

A

von Willebrand’s disease (0.1-1%)
See lots of bleeding
Give DDAVP

43
Q

Why would you test Factor 8 levels when testing for vWD?

A

Because vWF binds Factor 8 - problem could be with either one

44
Q

What is Bernard Soulier syndrome?

A

Deficiency of GPIb, which binds VWF to the platelet
Early childhood bruising
Give DDAVP

Diagnosis: increased bleeding time, giant platelets, thrombocytopenia, aggregation studies

45
Q

What is Glanzmann’s Thrombasthenia?

A

Big name, big molecule!!

Deficiency of GPIIv/IIIa - the big molecule that binds fibrinogen

Early childhood bruising, bleeding

46
Q

Causes of endothelial injury (6)

A
MI
Valve problems
Atherosclerosis
Vasculitis
Bacterial toxins
Cigarette
47
Q

Signs of endothelial injury (3)

A

Exposure of sub-endothelial collagen
Platelet activation
Adherence of platelets -> clotting cascade -> thrombotic state

48
Q

Causes of alteration in blood flow (2)

A

Turbulence (arterial/cardiac thrombosis)

Stasis (venous thrombosis)

49
Q

Causes of hypercoagulability (10)

A
Factor 5 Leiden
Antithrombin deficiency
Deficiency of anything in clotting factor pathway (protein C, protein S)
Bed rest
MI
Tissue damage
Cancer
DIC
Antiphospholipid antibody syndrome
Heparin-induced thrombocytopenia syndrome
50
Q

What is the result of the prothrombin 20210 mutation?

A

Increased prothrombin levels due to mRNA stabliity

51
Q

Name 5 causes of DIC.

A
Bacterial sepsis
Viremia
Trauma
Malignancies
Obstetric accidencts
52
Q

What is antiphospholipid antibody syndrome? Distinguish between primary and secondary APS. Briefly, what are the diagnostic criteria?

A

Aka Hughes syndrome
-> Arterial/venous thrombosis, thrombocytopenia, frequent miscarriages

Antiphospholipid antibodies -> hypercoagulable state

  • -Secondary APS: underlying autoimmune, like SLE
  • -Primary APS: no underlying autoimmune

Must have symptoms AND consistent phospholipid antibodies for >6 weeks

53
Q

What is heparin-induced thrombocytopenia syndrome?

A

Abnormal reaction to unfractionated heparin -> antibodies against Platelet Factor 4 -> activation of platelets -> prothrombotic state

54
Q

How do alterations in blood flow lead to thrombosis?

A

Disruption of laminar flow
Failed dilution of activated factors
Retard clotting factor inhibitors
Promotion of endothelial cell activation

55
Q

What is thrombocytopenia?

A

Low platelet count

56
Q

What could cause a prolonged PT time? (6)

A

Deficiencies of 7, 10, 5, 2, fibrinogen

Warfarin administration

57
Q

What can cause a prolonged PTT time? (6)

A

Deficiencies in 8, 9, 11, 12

Heparin
Lupus

58
Q

What are mixing studies?

A

Differentiate between coagulation factor deficiencies or presence of circulating anticoagulants/inhibitors as a cause of prolonged PT/PTT

Mix with fresh pooled normal plasma

PTT/PT will CORRECT if cause is factor deficiency
PTT/PT will NOT correct if cause is anticoagulant/inhibitor